{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:26:22Z","timestamp":1785306382892,"version":"3.55.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001349","name":"Singapore National Medical Research Council","doi-asserted-by":"crossref","award":["NMRC\/CNIG\/1101\/2013"],"award-info":[{"award-number":["NMRC\/CNIG\/1101\/2013"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Singapore Infectious Diseases Initiative","award":["SIDI\/2013\/006"],"award-info":[{"award-number":["SIDI\/2013\/006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A cost-minimization analysis was conducted for <jats:italic>Klebsiella pneumoniae<\/jats:italic> liver abscess (KLA) patients enrolled in a randomized controlled trial which found oral ciprofloxacin to be non-inferior to intravenous (IV) ceftriaxone in terms of clinical outcomes. Healthcare service utilization and cost data were obtained from medical records and estimated from self-reported patient surveys in a non-inferiority trial of oral ciprofloxacin versus IV ceftriaxone administered to 152 hospitalized adults with KLA in Singapore between November 2013 and October 2017. Total costs were evaluated by category and payer, and compared between oral and IV antibiotic groups over the trial period of 12\u00a0weeks. Among the subset of 139 patients for whom cost data were collected, average total cost over 12\u00a0weeks was $16,378 (95% CI, $14,620\u2013$18,136) for the oral ciprofloxacin group and $20,569 (95% CI, $18,296\u2013$22,842) for the IV ceftriaxone group, largely driven by lower average outpatient costs, as the average number of outpatient visits was halved for the oral ciprofloxacin group. There were no other statistically significant differences, either in inpatient costs or in other informal healthcare costs. Oral ciprofloxacin is less costly than IV ceftriaxone in the treatment of Klebsiella liver abscess, largely driven by reduced outpatient service costs.<\/jats:p><jats:p>Trial registration: ClinicalTrials.gov Identifier NCT01723150 (7\/11\/2012).<\/jats:p>","DOI":"10.1038\/s41598-023-36530-5","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T12:02:20Z","timestamp":1686916940000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cost-minimization analysis of oral versus intravenous antibiotic treatment for Klebsiella pneumoniae liver abscess"],"prefix":"10.1038","volume":"13","clinical-trial-number":[{"clinical-trial-number":"nct01723150","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Joanne","family":"Yoong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kah Hung","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S.","family":"Molton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boon Piang","family":"Cher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirin","family":"Kalimuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolene","family":"Oon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barnaby","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda M. A.","family":"Salada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tau Hong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li Min","family":"Wijaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezlyn","family":"Izharuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Moorakonda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Lye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Archuleta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,16]]},"reference":[{"key":"36530_CR1","doi-asserted-by":"publisher","first-page":"258514","DOI":"10.1155\/2013\/258514","volume":"2013","author":"Y Liu","year":"2013","unstructured":"Liu, Y., Wang, J.-Y. & Jiang, W. An increasing prominent disease of Klebsiella pneumoniae liver abscess: Etiology, diagnosis, and treatment. Gastroenterol. Res. Pract. 2013, 258514 (2013).","journal-title":"Gastroenterol. Res. Pract."},{"key":"36530_CR2","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S1473-3099(12)70205-0","volume":"12","author":"LK Siu","year":"2012","unstructured":"Siu, L. K., Yeh, K.-M., Lin, J.-C., Fung, C.-P. & Chang, F.-Y. Klebsiella pneumoniae liver abscess: A new invasive syndrome. Lancet Infect. Dis. 12, 881\u2013887 (2012).","journal-title":"Lancet Infect. Dis."},{"key":"36530_CR3","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1086\/519262","volume":"45","author":"C-T Fang","year":"2007","unstructured":"Fang, C.-T. et al. Klebsiella pneumoniae genotype K1: An emerging pathogen that causes septic ocular or central nervous system complications from pyogenic liver abscess. Clin. Infect. Dis. 45, 284\u2013293 (2007).","journal-title":"Clin. Infect. Dis."},{"key":"36530_CR4","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.jinf.2006.11.008","volume":"54","author":"DR Chung","year":"2007","unstructured":"Chung, D. R. et al. Emerging invasive liver abscess caused by K1 serotype Klebsiella pneumoniae in Korea. J. Infect. 54, 578\u2013583 (2007).","journal-title":"J. Infect."},{"key":"36530_CR5","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.12659\/AJCR.905191","volume":"18","author":"KG Oikonomou","year":"2017","unstructured":"Oikonomou, K. G. & Aye, M. Klebsiella pneumoniae liver abscess: A case series of six Asian patients. Am. J. Case Rep. 18, 1028\u20131033 (2017).","journal-title":"Am. J. Case Rep."},{"key":"36530_CR6","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/j.1572-0241.2005.40310.x","volume":"100","author":"ER Lederman","year":"2005","unstructured":"Lederman, E. R. & Crum, N. F. Pyogenic liver abscess with a focus on Klebsiella pneumoniae as a primary pathogen: An emerging disease with unique clinical characteristics. Am. J. Gastroenterol. 100, 322\u2013331 (2005).","journal-title":"Am. J. Gastroenterol."},{"key":"36530_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1757-4749-6-21","volume":"6","author":"J-C Lin","year":"2014","unstructured":"Lin, J.-C. et al. Genotypes and virulence in serotype K2 Klebsiella pneumoniae from liver abscess and non-infectious carriers in Hong Kong, Singapore and Taiwan. Gut Pathog. 6, 21 (2014).","journal-title":"Gut Pathog."},{"key":"36530_CR8","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1093\/cid\/ciz881","volume":"71","author":"JS Molton","year":"2020","unstructured":"Molton, J. S. et al. Oral vs intravenous antibiotics for patients with Klebsiella pneumoniae liver abscess: A randomized. Controlled Noninfer. Study. Clin. Infect. Dis. 71, 952\u2013959 (2020).","journal-title":"Controlled Noninfer. Study. Clin. Infect. Dis."},{"key":"36530_CR9","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1183\/09031936.00087209","volume":"35","author":"PK Lorgelly","year":"2010","unstructured":"Lorgelly, P. K. et al. Oral versus i.v. antibiotics for community-acquired pneumonia in children: A cost-minimisation analysis. Eur. Respir. J. 35, 858\u2013864 (2010).","journal-title":"Eur. Respir. J."},{"key":"36530_CR10","volume-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"MF Drummond","year":"2015","unstructured":"Drummond, M. F., Sculpher, M. J., Claxton, K., Stoddart, G. L. & Torrance, G. W. Methods for the Economic Evaluation of Health Care Programmes (Oxford University Press, Oxford, 2015)."},{"key":"36530_CR11","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/1745-6215-14-364","volume":"14","author":"J Molton","year":"2013","unstructured":"Molton, J. et al. Oral versus intravenous antibiotics for patients with Klebsiella pneumoniae liver abscess: Study protocol for a randomized controlled trial. Trials 14, 364 (2013).","journal-title":"Trials"},{"key":"36530_CR12","volume-title":"Cost-Effectiveness in Health and Medicine","year":"2016","unstructured":"Neumann, P. J. et al. (eds) Cost-Effectiveness in Health and Medicine (Oxford University Press, Oxford, 2016)."},{"key":"36530_CR13","unstructured":"Ministry of Health. Healthcare Schemes & Subsidies. https:\/\/www.moh.gov.sg\/cost-financing\/healthcare-schemes-subsidies (2020)."},{"key":"36530_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/(SICI)1099-1050(199601)5:1<13::AID-HEC182>3.0.CO;2-J","volume":"5","author":"J Posnett","year":"1996","unstructured":"Posnett, J. & Jan, S. Indirect cost in economic evaluation: The opportunity cost of unpaid inputs. Health Econ. 5, 13\u201323 (1996).","journal-title":"Health Econ."},{"key":"36530_CR15","unstructured":"Ministry of Manpower. Summary Table: Hours Worked. https:\/\/stats.mom.gov.sg\/Pages\/Hours-Worked-Summary-Table.aspx (2020)."},{"key":"36530_CR16","unstructured":"Department of Statistics Singapore. Yearbook of Statistics Singapore, 2019 (2019)."},{"key":"36530_CR17","unstructured":"StataCorp. Stata Statistical Software: Release 16. (2019)."},{"key":"36530_CR18","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1080\/14737167.2017.1360767","volume":"17","author":"EM Psaltikidis","year":"2017","unstructured":"Psaltikidis, E. M., da Silva, E. N., Bustorff-Silva, J. M., Moretti, M. L. & Resende, M. R. Economic evaluation of outpatient parenteral antimicrobial therapy: A systematic review. Expert Rev. Pharmacoecon. Outcomes Res. 17, 355\u2013375 (2017).","journal-title":"Expert Rev. Pharmacoecon. Outcomes Res."},{"key":"36530_CR19","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1056\/NEJMoa1808312","volume":"380","author":"K Iversen","year":"2018","unstructured":"Iversen, K. et al. Partial oral versus intravenous antibiotic treatment of endocarditis. N. Engl. J. Med. 380, 415\u2013424 (2018).","journal-title":"N. Engl. J. Med."},{"key":"36530_CR20","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1056\/NEJMoa1710926","volume":"380","author":"H-K Li","year":"2019","unstructured":"Li, H.-K. et al. Oral versus intravenous antibiotics for bone and joint infection. N. Engl. J. Med. 380, 425\u2013436 (2019).","journal-title":"N. Engl. J. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-36530-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-36530-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-36530-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T12:09:41Z","timestamp":1686917381000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-36530-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,16]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["36530"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-36530-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,16]]},"assertion":[{"value":"30 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9774"}}